DMLP:NASDAQDorchester Minerals, L.P. Analysis
Data as of 2026-06-18 - not real-time
$25.59
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Dorchester Minerals is trading just above a key support level and below its short‑term moving averages, indicating a price that is still pressured despite a solid fundamentals backdrop. The RSI sits in the lower range, hinting at potential oversold conditions, while the MACD is in a bearish alignment, suggesting further downside momentum in the near term. Volume has been picking up, which could signal a buildup of interest either for a reversal or continued selling. On the fundamentals side, the company delivers exceptionally high profit margins and strong revenue growth, supported by ample cash and a very modest debt profile. Return metrics such as ROE and ROA are robust, and the current PE is modestly below the industry average, pointing to a relative valuation discount. However, the DCF model projects a fair value far above the current price, implying a sizable upside if the business sustains its growth trajectory.
The energy royalty sector carries inherent commodity exposure, but DMLP’s diversified U.S. asset base mitigates geographic concentration risk. Market volatility is elevated, yet the stock’s beta is unusually low and even slightly negative, suggesting limited correlation with broader market swings. Liquidity appears constrained given the modest daily trading volume relative to market cap, which could amplify price swings on news or order flow. Overall, the blend of strong cash generation and a valuation gap makes the stock attractive for longer horizons, while short‑term technical signals advise caution.
The energy royalty sector carries inherent commodity exposure, but DMLP’s diversified U.S. asset base mitigates geographic concentration risk. Market volatility is elevated, yet the stock’s beta is unusually low and even slightly negative, suggesting limited correlation with broader market swings. Liquidity appears constrained given the modest daily trading volume relative to market cap, which could amplify price swings on news or order flow. Overall, the blend of strong cash generation and a valuation gap makes the stock attractive for longer horizons, while short‑term technical signals advise caution.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 4/10
Key Factors
- price near support with bearish MACD
- low RSI indicating oversold condition
- increasing volume but limited liquidity
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- strong revenue growth and high margins
- low debt and strong cash flow generation
- valuation discount relative to peers and DCF upside
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- sustainable royalty income model
- robust return on equity and assets
- significant upside potential from intrinsic value estimate
Key Metrics & Analysis
Financial Health
Revenue Growth36.40%
Profit Margin40.87%
P/E Ratio18.4
ROE21.52%
ROA13.23%
Debt/Equity0.24
P/B Ratio4.1
Op. Cash Flow$123.0M
Free Cash Flow$93.6M
Industry P/E19.9
Technical Analysis
TrendNeutral
RSI32.6
Support$25.59
Resistance$28.46
MA 20$27.14
MA 50$27.45
MA 200$25.35
MACDBearish
VolumeIncreasing
Fear & Greed Index91.07
Valuation
Fair Value$71.05
GradeUndervalued
TypeBlend
Risk Assessment
Beta-0.16
Volatility27.38%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.